Cetya Therapeutics' Grant

Cetya Therapeutics raised a round of funding on November 20, 2017. Investors include Colorado Office of Economic Development and International Trade.

Cetya Therapeutics develops drugs targeting epigenetic mechanisms for unmet medical needs. Cetya works on technology for a series of class I isoform specific histone deacetylase inhibitors that hold s…

Articles about Cetya Therapeutics' Grant: